IgG glycosylation changes and MBL2 polymorphisms: Associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis

Journal of Rheumatology

Volumn 39, Issue 3, 2012, Pages 463-469

  Troelsen, Lone N ^a   Jacobsen, Srøen ^a   Abrahams, Jodie L ^b   Royle, Louise ^b,c   Rudd, Pauline M ^b   Narvestad, Eva ^a   Heegaard, Niels H ^d   Garred, Peter ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c Culham Science Centre   (United Kingdom)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

Galactose; Immunoglobulin G; Mannose binding lectin; Prognosis; Rheumatoid arthritis; Risk factors

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GLUCOCORTICOID; IMMUNOGLOBULIN G; INTERLEUKIN 6; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AGE; AGED; ARTHROPLASTY; ARTICLE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATION; JOINT DESTRUCTION; MAJOR CLINICAL STUDY; MALE; MBL2 GENE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN GLYCOSYLATION; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION; INTERLEUKIN-6; JOINTS; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857813700     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110584     Document Type: Article

References (38)

1. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: Validation of a clinical activity score. Arthritis Res Ther 2005;7:796-806.
2. Van Leeuwen MA, Van Rijswijk MH, Sluiter WJ, van Riel PL, Kuper IH, van de Putte LB, et al. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system. J Rheumatol 1997;24:20-7. (Pubitemid 27059854)
3. Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ. Rheumatoid factor is the major predictor of increasing severity of radiographic erosions in rheumatoid arthritis: Results from the Norfolk Arthritis Register Study, a large inception cohort. Arthritis Rheum 2002;46:906-12. (Pubitemid 34303801)
4. Quinn MA, Gough AK, Green MJ, Devlin J, Hensor EM, Greenstein A, et al. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology 2006;45:478-80.
5. van Gaalen FA, van Aken J, Huizinga TW, Schreuder GM, van Breedveld FC, Zanelli E, et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004;50:2113-21. (Pubitemid 38924388)
6. Parekh RB, Dwek RA, Sutton BJ, Fernandes DL, Leung A, Stanworth D, et al. Association of rheumatoid arthritis and primary osteo-arthritis with changes in the glycosylation pattern of total serum IgG. Nature 1985;316:452-7. (Pubitemid 16238456)
7. Parekh R, Roitt I, Isenberg D, Dwek R, Rademacher T. Age-related galactosylation of the N-linked oligosaccharides of human serum IgG. J Exp Med 1988;167:1731-6.
8. Yamada E, Tsukamoto Y, Sasaki R, Yagyu K, Takahashi N. Structural changes of immunoglobulin G oligosaccharides with age in healthy human serum. Glycoconj J 1997;14:401-5. (Pubitemid 27231681)
9. Ercan A, Cui J, Chatterton DE, Deane KD, Hazen MM, Brintnell W, et al. IgG galactosylation aberrancy precedes disease onset, correlates with disease activity and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum 2010;62:2239-48.
10. Gindzienska-Sieskiewicz E, Klimiuk PA, Kisiel DG, Gindzienski A, Sierakowski S. The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis. Clin Rheumatol 2007;26:685-90. (Pubitemid 46554073)
11. Lacki JK, Porawska W, Mackiewicz U, Mackiewicz S, Muller W. Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis. Ann Med 1996;28:265-9. (Pubitemid 26191065)
12. Pasek M, Duk M, Podbielska M, Sokolik R, Szechinski J, Lisowska E, et al. Galactosylation of IgG from rheumatoid arthritis (RA) patients - Changes during therapy. Glycoconj J 2006;23:463-71. (Pubitemid 44477391)
13. Vanzeben D, Rook GAW, Hazes JMW, Zwinderman AH, Zhang Y, Ghelani S, et al. Early agalactosylation of IgG is associated with a more progressive disease course in patients with rheumatoid arthritis - Results of a follow-up study. Br J Rheumatol 1994;33:36-43. (Pubitemid 24042034)
14. Garred P, Larsen F, Madsen HO, Koch C. Mannose-binding lectin deficiency - revisited. Mol Immunol 2003;40:73-84. (Pubitemid 36959818)
15. Graudal NA, Madsen HO, Tarp U, Svejgaard A, Jurik AG, Graudal HK, et al. The association of variant mannose-binding lectin genotypes with radiographic outcome in rheumatoid arthritis. Arthritis Rheum 2000;43:515-21. (Pubitemid 30394941)
16. Jacobsen S, Madsen HO, Klarlund M, Jensen T, Skjodt H, Jensen KE, et al. The influence of mannose binding lectin polymorphisms on disease outcome in early polyarthritis. J Rheumatol 2001;28:935-42. (Pubitemid 32422570)
17. Barton A, Platt H, Salway F, Symmons D, Lunt M, Worthington J, et al. Polymorphisms in the mannose binding lectin (MBL) gene are not associated with radiographic erosions in rheumatoid or inflammatory polyarthritis. J Rheumatol 2004;31:442-7. (Pubitemid 38337600)
18. Van de Geijn FE, Hazes JM, Geleijns K, Emonts M, Jacobs BC, Dufour-van den Goorbergh BC, et al. Mannose-binding lectin polymorphisms are not associated with rheumatoid arthritis -Confirmation in two large cohorts. Rheumatology 2008;47:1168-71. (Pubitemid 352038221)
19. Jacobsen S, Garred P, Madsen HO, Heegaard NH, Hetland ML, Stengaard-Pedersen K, et al. Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis. J Rheumatol 2009; 36:731-5.
20. Saevarsdottir S, Steinsson K, Grondal G, Valdimarsson H. Patients with rheumatoid arthritis have higher levels of mannan-binding lectin than their first-degree relatives and unrelated controls. J Rheumatol 2007;34:1692-5.
21. Troelsen LN, Garred P, Jacobsen S. Mortality and predictors of mortality in rheumatoid arthritis - A role for mannose-binding lectin? J Rheumatol 2010;37:536-43.
22. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med 1995;1:237-43.
23. Troelsen LN, Garred P, Madsen HO, Jacobsen S. Genetically determined high serum levels of mannose-binding lectin and agalactosyl IgG are associated with ischemic heart disease in rheumatoid arthritis. Arthritis Rheum 2007;56:21-9. (Pubitemid 46106175)
24. Garred P, Madsen HO, Marquart H, Hansen TM, Sorensen SF, Petersen J, et al. Two edged role of mannose binding lectin in rheumatoid arthritis: A cross sectional study. J Rheumatol 2000;27:26-34. (Pubitemid 30058625)
25. Royle L, Campbell MP, Radcliffe CM, White DM, Harvey DJ, Abrahams JL, et al. HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem 2008;376:1-12.
26. Troelsen LN, Garred P, Christiansen B, Torp-Pedersen C, Christensen IJ, Narvestad E, et al. Double role of mannose-binding lectin in relation to carotid intima-media thickness in patients with rheumatoid arthritis. Mol Immunol 2010;47:713-8.
27. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
28. van der Heijde DM. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-3.
29. Campbell MP, Royle L, Radcliffe CM, Dwek RA, Rudd PM. GlycoBase and autoGU: Tools for HPLC-based glycan analysis. Bioinformatics 2008;24:1214-6. (Pubitemid 351594175)
30. Madsen HO, Garred P, Thiel S, Kurtzhals JAL, Lamm LU, Ryder LP, et al. Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol 1995;155:3013-20.
31. Burton DR, Dwek RA. Immunology. Sugar determines antibody activity. Science 2006;313:627-8. (Pubitemid 44201132)
32. Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006;313:670-3. (Pubitemid 44201145)
33. Gornik I, Maravic G, Dumic J, Flogel M, Lauc G. Fucosylation of IgG heavy chains is increased in rheumatoid arthritis. Clin Biochem 1999;32:605-8. (Pubitemid 30039088)
34. Flogel M, Lauc G, Gornik I, Macek B. Fucosylation and galactosylation of IgG heavy chains differ between acute and remission phases of juvenile chronic arthritis. Clin Chem Lab Med 1998;36:99-102. (Pubitemid 28156059)
35. Shields RL, Lai J, Keck R, O'Connell LY, Hong K, Meng YG, et al. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fc-gamma RIII and antibody-dependent cellular toxicity. J Biol Chem 2002;277:26733-40. (Pubitemid 34951677)
36. Holland M, Takada K, Okumoto T, Takahashi N, Kato K, Adu D, et al. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis. Clin Exp Immunol 2002;129:183-90.
37. Martin K, Talukder R, Hay FC, Axford JS. Characterization of changes in IgG associated oligosaccharide profiles in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis using fluorophore linked carbohydrate electrophoresis. J Rheumatol 2001;28:1531-6. (Pubitemid 32660624)
38. Shinzaki S, Iijima H, Nakagawa T, Egawa S, Nakajima S, Ishii S, et al. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease. Am J Gastroenterol 2008;103:1173-81. (Pubitemid 351677959)